| SAVR volumes alone not predictive of TAVR outcomes—but combined experience is |
| Dialysis raises short-term death risk in kidney patients undergoing TAVI |
| Women’s BP, heart rates regularly shift to meet social, physical demands |
| Will another adjunct to statins fit in the cholesterol drug market? |
| Robotic arm therapy linked to improved speech in chronic stroke patients |
| Vitamin D levels in blood tied to cardiorespiratory fitness |
| Lower blood pressure, BMI may precede dementia |
| AHA, CHF funnel $776K into congenital heart defect research |
| NHS England: 500 diabetics die each week from preventable complications |
| Canagliflozin becomes first oral diabetes drug approved to reduce MACE |
| Beta-blockers, RASBs reduce mortality in HF patients with midrange EF |
| NIH pauses $63M stem cell trial for heart failure amid controversy |
| Most cases of SCAD can’t be traced back to apparent risk factors |
| Wider thrombectomy window chosen as No. 3 medical innovation for 2019 |
| Taking donor heart at increased disease risk is better than waiting |
| Novel vaccine could work as well as clopidogrel to prevent ischemic stroke |
| New risk score distinguishes inpatient strokes from other conditions |
| ROI tool helps communities craft cost-effective CVD prevention plans |
| Augmented reality allows 3D visualization of myocardial scar during ablation |
| Evolocumab cuts LDL, CV events in patients with kidney disease |
| Expanding mammography reporting could ID women at risk of CVD |
| iSchemaView’s RAPID™ Adopted by More Than 700 Stroke Centers — Over 100 Percent Growth This Year |
| Patricia Blake named new CEO of Heart Rhythm Society |
| Omega-3 slashes GI bleeding rates for LVAD patients |
| CTA reclassifies long-term cardiac risk in 68% of patients |
| Viewpoint: Academic missions, physicians suffer in RVU system |
| Cardiac MRI shows potential for noninvasive pulmonary hypertension diagnosis |
| MRI-based small vessel disease score linked to future stroke, dementia |
| Time to nearest PCI hospital determines reperfusion strategy in STEMI |
| Eko Collaborates with Mayo Clinic on a Machine Learning-Based Algorithm to Help Physicians Better Screen for Potentially Dangerous Heart Diseases |
| Amgen cuts price of PCSK9 inhibitor by 60% |
| Fall, winter weather linked to increased risk of MI |
| AFib’s impact on heart failure outcomes varies by subtype |
| Why obese women might combat CVD, diabetes better than obese men |
| TAVR offers improved neurological outcomes, quality of life over SAVR |
| Busiest EDs produce best outcomes for patients with chest pain |
| Cardiology malpractice suits up 91% from a decade ago |
| Medtronic co-founder and pacemaker inventor Earl Bakken dies at age 94 |
| Researchers ID genetic variant associated with warfarin-related bleeding |
| Poorly controlled BP elevates risk of hypertensive emergencies in diabetics |
| Omega-3 supplements improve social function, reduce depression in HF patients |
| TAVR shows ‘excellent safety’ at 30 days in low-risk patients |
| Finding balance: What marijuana legalization means for heart patients |
| Researchers highlight possible ‘neglected risk factor’ for MI |
| Medtronic Receives FDA Approval for Valiant Navion(TM) Thoracic Stent Graft System |
| Phone app boosts weight loss among low-income patients |
| Study: There’s no such thing as ‘too fit’ |
| Canada introduces tiered CVD screening for high school athletes |
| Baylor St. Luke’s hires surgeons, administrator to revive struggling heart transplant program |
| Report: BP lower in those with good oral health |
| Coronary artery calcium signals greatest mortality risk in blacks, Hispanics |
| FDA axes bid to add CVD indication for canakinumab |
| How much exercise is enough to counteract heart disease? |
| Medtronic Co-Founder Earl Bakken Passes Away at Age 94 |
| Aspirin enough to prevent VTE after knee replacement surgery |
| Recreational cannabis use linked to increased risk of stroke |
| Phone app connects CPR-certified locals to nearby cardiac arrests |
| Novel risk predictor identifies likelihood of readmission after AMI |
| Researchers call for halt of $63M cardiac stem cell trial |
| HeartMate 3 heart pump gets FDA approval as destination therapy |
| Transcranial sonography predicts functional outcome after stroke thrombectomy |
| Nonfemoral TAVR tied to greater mortality in frail seniors |
| Silicon Valley is investing in top-tier cardiologists—here’s why |
| Bariatric surgery linked to 40% reduction in CV events for type 2 diabetics |
| Boston Children’s criteria IDs kids at risk for arrhythmias during stress tests |
| RV strain analysis improves risk predictions for acute decompensated HF |
| Image-guided atherectomy system for smaller vessels gains CE mark |
| Bedside troponin test can rule out AMI within 15 minutes |
| AHA, AMA recognize 802 practices for efforts to control hypertension |
| Prior PCI does little to affect CABG outcomes |
| Why Cleveland Clinic began screening carpal tunnel patients for cardiac amyloidosis |
| An alternative to exercise: Chemical may lower BP without lifestyle changes |
| Minnesota AG sues drugmakers over rising insulin costs |
| Catheter ablation safer than surgery for paroxysmal or early persistent AFib |
| Are part-time cardiologists, diagnostic caths fading away? |
| Purdue introduces cardiology’s latest wearable: A paper-thin, plant-based sticker |
| Kids who eat energy-dense, low-nutrition breakfasts at risk for insulin resistance, elevated HDL |
| Complete revascularization tops culprit-only PCI for long-term survival after NSTEMI |
| Leapfrog Group to expand ratings to 5,600 surgery centers |
| Anticoagulation after ICH linked to better odds of functional recovery |
| Harvard, Brigham and Women’s press for 31 retractions of cardiac stem cell research |
| Prior cardiotoxicity linked to 30% increased risk of CHF during pregnancy |
| Study debunks idea of ‘weekend effect’ after major cardiac surgery |
| CMS to reconsider reimbursement for ambulatory BP monitoring |
| Heart disease rising in underdeveloped regions, where 75% of CVD deaths occur |
| Robert Ford named president, COO of Abbott |
| Heart valve surgery linked to transient declines in cognitive function |
| Researchers develop 1st mini pacemaker capable of long-term mouse studies |
| Cardiologist invests $60M in future of sirolimus-coated balloons |
| Registry study details advancement of CTO interventions in Europe |
| Longer hospital stays after elective PCI mean higher costs, more readmissions |
| Elevated levels of cystatin C linked to 28% increased risk of CVD after ACS |
| FDA OKs rivaroxaban for CV event reduction in patients with CAD, PAD |
| Researcher urges caution when considering fibrinolytics for elderly STEMI patients |
| Brexit backlash: UK patients pulled from international heart drug trial |
| Antiepileptic drugs boost stroke risk in Alzheimer’s patients |
| Cardiac rehab uptake lagging in China |
| Cardiogenic shock signals complexity in takotsubo patients |
| Silent heart attacks equally deadly in long run |
| The CVD patient’s guide to Hurricane Michael |
